Global  

Lymphoma

Latest news and video coverage curated from trusted media outlets

0
shares
ShareTweetSavePostSend
 
Mayo Clinic Blood Donor program launches "Giving for Garrett" campaign [Video]

Mayo Clinic Blood Donor program launches "Giving for Garrett" campaign

Walk-ins aren't allowed right now, but you can still make an appointment to donate.

Credit: KIMTPublished
Local Chiefs fan selected as NFL Fan of the Year nominee [Video]

Local Chiefs fan selected as NFL Fan of the Year nominee

Local Chiefs fan selected as NFL Fan of the Year nominee

Credit: KQTVPublished

SD firefighters rally around firefighter battling cancer [Video]

SD firefighters rally around firefighter battling cancer

Firefighters rally around firefighter battling cancer

Credit: ABC 10 News | San Diego     Duration: 02:05Published
11092020 Lung cancer awareness [Video]

11092020 Lung cancer awareness

Amber talked to someone about how to get a lung cancer screening

Credit: WTVQ Lexington, KYPublished
'Light The Night' Virtual Walk [Video]

'Light The Night' Virtual Walk

Saturday, beginning at 7pm, for the Leukemia & Lymphoma Society

Credit: KTNV Channel 13 Las Vegas     Duration: 05:16Published
Jeff Bridges 'appreciating mortality' after cancer diagnosis [Video]

Jeff Bridges 'appreciating mortality' after cancer diagnosis

Jeff Bridges says he is "appreciating his mortality", since being diagnosed with lymphoma.

Credit: Cover Video STUDIO     Duration: 00:52Published
Dad living with cancer does 176,200 pushups [Video]

Dad living with cancer does 176,200 pushups

About 176,200 people are diagnosed with a blood cancer in the U.S. every year. Nathan Tirey did a pushup for each one of them.

Credit: USA Today Kind (International)     Duration: 00:57Published
NEWS OF THE WEEK: Jeff Bridges diagnosed with lymphoma [Video]

NEWS OF THE WEEK: Jeff Bridges diagnosed with lymphoma

Jeff Bridges has been diagnosed with lymphoma.

Credit: Cover Video STUDIO     Duration: 00:46Published
Scotts Valley High School keeps tradition alive with drive-thru haunted house [Video]

Scotts Valley High School keeps tradition alive with drive-thru haunted house

All of the profits go to the Leukemia and Lymphoma Society.

Credit: KSBW     Duration: 02:01Published
WCBI NEWS at 10 - 10/21/2020 [Video]

WCBI NEWS at 10 - 10/21/2020

WCBI NEWS at 10 - 10/21/2020

Credit: WCBIPublished
Jeff Bridges Reveals He Has Been Diagnosed with Lymphoma and Is Starting Treatment [Video]

Jeff Bridges Reveals He Has Been Diagnosed with Lymphoma and Is Starting Treatment

The True Grit star confirmed the news of his diagnosis on Twitter

Credit: People     Duration: 01:00Published
Jeff Bridges Has Lymphoma—Here's What to Know About This Form of Cancer, and What His Trea [Video]

Jeff Bridges Has Lymphoma—Here's What to Know About This Form of Cancer, and What His Trea

"As the Dude would say… New S**T has come to light," the actor revealed in a tweet.

Credit: Health.com     Duration: 01:06Published
Jeff Bridges Reveals Lymphoma Cancer Diagnosis In Heart Breaking Post [Video]

Jeff Bridges Reveals Lymphoma Cancer Diagnosis In Heart Breaking Post

Jeff Bridges makes a heart breaking announcement. Emma Roberts once blocked her mom. Plus - Jamie Lynn Spears opens up about being 16 and pregnant.

Credit: Hollywood Life     Duration: 01:53Published
Jeff Bridges Reveals He's Been Diagnosed With Lymphoma | THR News [Video]

Jeff Bridges Reveals He's Been Diagnosed With Lymphoma | THR News

Jeff Bridges revealed on Monday afternoon that he has been diagnosed with lymphoma.

Credit: THR News     Duration: 01:21Published
Jeff Bridges Diagnosed With Lymphoma [Video]

Jeff Bridges Diagnosed With Lymphoma

Stars from across Hollywood are sharing their love and support for Oscar-winner and beloved actor, Jeff Bridges, who just revealed he's been diagnosed with lymphoma.

Credit: ETCanada     Duration: 01:17Published
Actor Jeff Bridges has announced he's been diagnosed with lymphoma [Video]

Actor Jeff Bridges has announced he's been diagnosed with lymphoma

Oscar-winning actor Jeff Bridges revealed to fans on Twitter that he's been diagnosed with lymphoma, a cancer of the lymphatic system.

Credit: USA Today Entertainment (Domesti     Duration: 00:58Published
Jeff Bridges Starting Treatment After Being Diagnosed With Lymphoma [Video]

Jeff Bridges Starting Treatment After Being Diagnosed With Lymphoma

Jeff Bridges announced Monday evening he has been diagnosed with lymphoma and is starting treatment.

Credit: CBS 2 New York     Duration: 00:30Published
'The prognosis is good': Jeff Bridges diagnosed with lymphoma [Video]

'The prognosis is good': Jeff Bridges diagnosed with lymphoma

Jeff Bridges has been diagnosed with lymphoma but has been given a "good prognosis".

Credit: Bang Media International Limited     Duration: 01:19Published
Jeff Bridges Is Diagnosed With Lymphoma Cancer [Video]

Jeff Bridges Is Diagnosed With Lymphoma Cancer

CNN reports that Jeff Bridges has been diagnosed with lymphoma. The acclaimed actor shared the news with fans on Monday on Twitter. He tweeted, "Although it is a serious disease, I feel fortunate..

Credit: Wochit     Duration: 00:35Published
Baltimore Buzz: Jeff Bridges Has Lymphoma [Video]

Baltimore Buzz: Jeff Bridges Has Lymphoma

Here's what's trending in Baltimore.

Credit: WJZ Baltimore     Duration: 01:38Published
Jeff Bridges diagnosed with lymphoma [Video]

Jeff Bridges diagnosed with lymphoma

Jeff Bridges has been diagnosed with lymphoma.

Credit: Cover Video STUDIO     Duration: 00:46Published
4-Year-old Miami Boy Battling Acute Lymphoblastic Leukemia Gets Special Parade [Video]

4-Year-old Miami Boy Battling Acute Lymphoblastic Leukemia Gets Special Parade

CBS4's Brooke Shafer shares the special day for 4-year-old Leonardo.

Credit: CBS4 Miami     Duration: 01:42Published
WCBI NEWS at 10 - 10/10/2020 [Video]

WCBI NEWS at 10 - 10/10/2020

WCBI NEWS at 10 - 10/10/2020

Credit: WCBIPublished
WCBI New at Six - 10/10/2020 [Video]

WCBI New at Six - 10/10/2020

WCBI New at Six - 10/10/2020

Credit: WCBIPublished
CANCER FREE [Video]

CANCER FREE

A Starkville family learned their 18 month old daughter had a form of pediatric cancer in 2018 but she is now cancer free.

Credit: WCBIPublished

You Might Like


Global Gene Therapy Market Report 2020-2027: Market is Projected to Reach a Revised $3.3 Billion

Dublin, Nov. 27, 2020 (GLOBE NEWSWIRE) -- The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to *ResearchAndMarkets.com's* offering. *In a Major Setback to the..
GlobeNewswire - Published

Approval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for the Treatment of Myelodysplastic Syndrome

SHANGHAI and HONG KONG, Nov. 26, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", HKSE stock code: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering,..
PR Newswire Asia - Published

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM

NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Molecular Templates, Inc. (“Molecular” or the “Company”) (NASDAQ: MTEM). Such..
GlobeNewswire - Published

Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

· Studies reinforce clonoSEQ as standard of care in minimal residual disease (MRD) across eight disease states· Real-world evidence shows treatment decisions based on precise MRD measurement directly..
GlobeNewswire - Published

Silicon Therapeutics Announces Dosing of First Patient in Phase 1 Open-Label Clinical Trial of SNX281 for Advanced Solid Tumors or Lymphoma

silicon therapeutics announces dosing of first patient in phase 1 open-label clinical trial of snx281 for advanced solid tumors or lymphoma
BOSTON--(BUSINESS WIRE)-- #AI--Silicon Therapeutics announces treatment of first patient with its therapeutic candidate SNX281 in a Phase 1 clinical trial.
Business Wire - Published

Lucintel Anticipates that North America Will be the Fastest Growing Region in the Cancer Biomarker Market

lucintel anticipates that north america will be the fastest growing region in the cancer biomarker market
*DALLAS, TX / ACCESSWIRE / November 23, 2020 / *According to a new market report published by Lucintel, the future of the cancer biomarker market looks promising with opportunities in the diagnostics,..
Accesswire - Published

SinoMab Commenced Construction of its China Headquarters

HONG KONG, Nov 23, 2020 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research,..
ACN Newswire - Published

ESMO ASIA Congress 2020 | CStone Pharmaceuticals announces the results of GEMSTONE-302, Sugemalimab has the potential to provide a new treatment option for patients with advanced NSCLC

SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO)..
PR Newswire Asia - Published

Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020

SAN FRANCISCO and SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and..
PR Newswire Asia - Published

Jeff Bridges ‘Isn’t Ready To Throw In The Towel’ — Inside His Brave Cancer Battle

Fans were shocked and heartbroken when Jeff Bridges took to Twitter in late October to reveal he’d been diagnosed with lymphoma at age 70. “Although it is a serious disease, I feel fortunate that I..
OK! Magazine - Published

Antengene Corporation, an Innovative Cancer Biotech Company, is Listed on the Main Board of the Hong Kong Stock Exchange

HONG KONG, Nov. 20, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leader in discovery, development and commercialization of innovative cancer medicines, today..
PR Newswire Asia - Published

ADC Therapeutics Announces FDA Accepts Biologics License Application and Grants Priority Review for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

adc therapeutics announces fda accepts biologics license application and grants priority review for loncastuximab tesirine for treatment of relapsed or refractory diffuse large b-cell lymphoma
LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT), a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent..
Business Wire - Published

CARsgen Therapeutics to Present Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition in December

SHANGHAI, Nov. 20, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company, today announced that data from its global multiple myeloma program will be presented, including..
PR Newswire Asia - Published

Cricket: Canterbury seamer Andrew Hazeldine to miss domestic summer due to Hodgkin lymphoma diagnosis

cricket: canterbury seamer andrew hazeldine to miss domestic summer due to hodgkin lymphoma diagnosis
A New Zealand first-class cricketer's career has been put on hold after being diagnosed with cancer.Canterbury left-arm fast bowler Andrew Hazeldine, 26, was told in September he had Hodgkin lymphoma..
New Zealand Herald - Published

Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002

Trial to Evaluate Ability of BP1002, Targeting Bcl-2 Protein, to Treat Refractory/Relapsed Lymphoma and Chronic Lymphocytic Leukemia Patients HOUSTON, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Bio-Path..
GlobeNewswire - Published

Results from Phase 3 CROWN Trial of Pfizer’s LORBRENA® (lorlatinib) in Previously Untreated ALK-Positive Lung Cancer Published in the New England Journal of Medicine

results from phase 3 crown trial of pfizer’s lorbrena® (lorlatinib) in previously untreated alk-positive lung cancer published in the new england journal of medicine
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced results from the Phase 3 CROWN trial of LORBRENA® (lorlatinib, available in Europe under the brand name LORVIQUA®) versus XALKORI®..
Business Wire - Published

Global Gene Therapy Industry

In a Major Setback to the Healthcare System, Non-COVID-19 Care Delivery Bears the Brunt of the Pandemic. Gene Therapy Market Slumps by -13. 6%. The global market for Gene Therapy is expected to decline..
GlobeNewswire - Published

Hemogenyx Pharmaceuticals plc announces Financing Facility of up to £60 Million

hemogenyx pharmaceuticals plc announces financing facility of up to £60 million
*NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT..
Accesswire - Published

Oncternal Therapeutics Increases Previously Announced Bought Deal to $22.5 Million

SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today..
GlobeNewswire - Published

Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering

SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today..
GlobeNewswire - Published

Kazia Therapeutics sets sights on advancing near-term paxalisib commercialisation plans

Kazia Therapeutics Ltd (ASX:KZA) enjoyed a productive September quarter, advancing the development of its product candidates, according to chief executive officer Dr James Garner. He said: “The..
Proactive Investors - Published

Axiom Presenting “Simplifying the Complex Data and Operational Awareness Needs of Oncology Studies Using Unified eClinical Tech” at Clinical Operations in Oncology Trials USA 2020: A Virtual Experience

TORONTO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, is a presenting sponsor and exhibitor at Clinical..
GlobeNewswire - Published

Preserving Courtroom And Verdict Integrity – OpEd

preserving courtroom and verdict integrity – oped
Big Media, Big Tech, Big Academia, the Deep State and the Cancel Culture clearly aligned with the Democrat Party, to resist, block, impede and impeach a duly elected President Trump, during and after..
Eurasia Review - Published

RAPT Therapeutics Reports Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications

-Evidence of Monotherapy and Combination Activity in Charged Tumor Types- -Company Advances Several Cohorts into Phase 2 Expansions- -Conference Call and Webcast to be Held at 8:30 a.m. ET..
GlobeNewswire - Published

CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

chmp adopted positive opinion for elzonris (tagraxofusp), for the treatment of blastic plasmacytoid dendritic cell neoplasm (bpdcn)
The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN If approved by the European Commission, ELZONRIS will be the first approved treatment for patients..
PR Newswire Asia - Published

VolitionRx ends 3Q with $21M in cash as it prepares to launch Nu.Q Vet Cancer Screening Test

VolitionRx Limited (NYSEAMERICAN:VNRX) said Thursday it ended its third quarter with cash and cash equivalents of about $21 million as it prepares to launch its first product  -- the Nu.Q Vet Cancer..
Proactive Investors - Published

Xenetic Biosciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Corporate Update

xenetic biosciences, inc. reports third quarter 2020 financial results and provides corporate update
*- Continued Advancement of XCART™ Platform Towards an IND Filing and Phase 1 Study* *- Leveraging Partnerships With Leading Global Academic Institutions, Including Scripps..
Accesswire - Published

Insights on the Worldwide Nuclear Medicine Market to 2025 - Featuring GE Healthcare, Siemens Healthineers & Rotem Industries Among Others

Dublin, Nov. 13, 2020 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine Market By Therapy (Radioactive Iodine, Radioactive Antibodies, Others), By Type (SPECT, PET, Alpha-emitters, Beta-emitters,..
GlobeNewswire - Published

Bio-Path Holdings Reports Third Quarter 2020 Financial Results

Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™..
GlobeNewswire - Published

TG Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference

Fireside chat scheduled for Tuesday, November 17, 2020 at 2:20 PM ET/ 7:20 PM GMT NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S...
GlobeNewswire - Published

Vision 20 Reviews - Groundbreaking New Report on Vision 20 for Eyesight

Vision 20 by Zenith Labs is an eye care supplement that, by its ingredients, tries to protect your eyesight. Houston, TX , Nov. 13, 2020 (GLOBE NEWSWIRE) -- Vision 20 is a dietary supplement that..
GlobeNewswire - Published

EMA grants PRIME tag to Innate Pharma's lacutamab for T-cell lymphoma


SeekingAlpha - Published

Kiadis announces presentations at the 2020 ASH Annual Meeting and Exposition

*Amsterdam, The Netherlands, November 13, 2020 – Kiadis Pharma N.V. ("Kiadis" or the "Company") (Euronext Amsterdam and Brussels: KDS)*, a clinical-stage biopharmaceutical company developing..
GlobeNewswire - Published

Innate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in Sézary Syndrome

Priority Medicines (PRIME) designation supports the potential for lacutamab to benefit Sézary Syndrome patients in need of new treatment options MARSEILLE, France, Nov. 13, 2020 (GLOBE NEWSWIRE) --..
GlobeNewswire - Published

Soligenix, Inc. to Present at the virtual Fall Investor Summit on November 16th-18th

soligenix, inc. to present at the virtual fall investor summit on november 16th-18th
*NEW YORK, NY / ACCESSWIRE / November 12, 2020 /* Soligenix, Inc. (NASDAQ:SNGX),* *a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where..
Accesswire - Published

CStone Pharmaceuticals Announces China's NMPA has Accepted its New Drug Application for anti-PD-L1 Monoclonal Antibody Sugemalimab in First-Line Advanced NSCLC

· Currently, there is no anti-PD-L1 monoclonal antibody approved for stage IV NSCLC in China · An oral presentation of specific clinical trial data of CS1001-302 study will be given at ESMO Asia..
PR Newswire Asia - Published

MorphoSys Reports Nine Months and Third Quarter 2020 Results

morphosys reports nine months and third quarter 2020 results
*Conference call and webcast (in English) to be held on November 12, 2020 at 2:00pm CET (1:00pm GMT/8:00am EST)* *PLANEGG / MUNICH, GERMANY/ ACCESSWIRE / November 11, 2020 / *MorphoSys AG (FSE:MOR)..
Accesswire - Published Also reported by •EQS Group

MorphoSys and Cherry Biolabs Announce Licensing of Hemibody Technology

morphosys and cherry biolabs announce licensing of hemibody technology
*The parties signed a multi-target exclusive licensing agreement for application of Cherry Biolabs' Hemibody technology * *Combination with MorphoSys' antibody know-how enables discovery and..
Accesswire - Published Also reported by •EQS Group

Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab

xencor, morphosys and incyte enter into global development collaboration for tafasitamab in combination with plamotamab
*MONROVIA, CA, PLANEGG/MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / November 11, 2020 /* Xencor (XNCR), MorphoSys AG (FSE:MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ:MOR) and Incyte (INCY)..
Accesswire - Published Also reported by •Business WireEQS Group

CAP and ASCP Announce Laboratory Workup of Lymphoma in Adults Guideline

cap and ascp announce laboratory workup of lymphoma in adults guideline
CHICAGO--(BUSINESS WIRE)-- #pathologists--The CAP and the ASCP have released a new evidence-based clinical practice guideline, “Laboratory Workup of Lymphoma in Adults.”
Business Wire - Published

NA Proactive news snapshot: Gevo, CleanSpark, KushCo Holdings, Water Tower Research, LeanLife Health, ElectraMeccanica UPDATE …

Gevo Inc (NASDAQ:GEVO), citing a strong balance sheet and available cash, said Tuesday it expects to pay off its entire outstanding secured debt balance of $12.7 million by year’s end. The company..
Proactive Investors - Published

CoImmune, Inc. Announces Closing of $45 Million Series A Financing

DURHAM, N.C., Nov. 10, 2020 (GLOBE NEWSWIRE) -- CoImmune, Inc., an immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications,..
GlobeNewswire - Published

NA Proactive news snapshot: African Gold Group, Inc, Predictmedix Inc, Royal Road Minerals Limited, VolitionRx Limited, Melkior Resources Inc, Nomad Royalty UPDATE …

African Gold Group, Inc (CVE:AGG) (ASX:A1G) (OTCMKTS:AGGFF) Tuesday announced that its team is helping local stakeholders keep key roads and infrastructure open in Mali, West Africa, in what has been..
Proactive Investors - Published

VolitionRx says veterinary oncology experts contribute to report ahead of Nu.Q Vet Cancer Screening Test launch

VolitionRx Limited (NYSEAMERICAN:VNRX) announced a report Tuesday with contributions from four global leaders in veterinary oncology ahead of the expected launch of its first animal-test product -- the..
Proactive Investors - Published

Innovative Cellular Therapeutics to Present CoupledCAR® Solid Tumor CAR-T Clinical Data at Upcoming Scientific Meetings

ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor (CAR) T..
GlobeNewswire - Published

Affimed Reports Third Quarter 2020 Financial Results and Highlights Recent Operational Progress

· Established license and strategic collaboration with Roivant Sciences - $60 million in upfront consideration and up to $2 billion in future milestones · Recognized milestone payment from Genentech..
GlobeNewswire - Published



 Page 1  〉